Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Vermeer

Showing results (191-200 of 201) with videos related to

Pageof 21
Sort By:
Science Translational Medicine|July 22, 2021
Dynamic loading of human engineered heart tissue enhances contractile function and drives a desmosome-linked disease phenotypeJacqueline M Bliley, Mathilde C S C Vermeer, Rebecca M Duffy, et al.
JACC. Cardiooncology|July 3, 2023
Evaluation of Senescence and Its Prevention in Doxorubicin-Induced Cardiotoxicity Using Dynamic Engineered Heart TissuesAnnet N Linders, Itamar B Dias, Ekaterina S Ovchinnikova, et al.
Clinical Lung Cancer|April 22, 2025
The Toxicity Profile of Pemetrexed in Non-Small Cell Lung Cancer Patients With Moderate Renal Impairment: A Retrospective Cohort StudyMart P Kicken, Rob Ter Heine, Intissar Azarfane, et al.
Circulation. Genomic and Precision Medicine|May 18, 2023
Genetic Burden of <i>TNNI3K</i> in Diagnostic Testing of Patients With Dilated Cardiomyopathy and Supraventricular ArrhythmiasCaroline Pham, Karolina Andrzejczyk, Sean J Jurgens, et al.
Circulation. Genomic and Precision Medicine|April 10, 2026
Novel RYR2-A4510T Variant Presenting Both as Autosomal Dominant and Autosomal Recessive Catecholaminergic Polymorphic Ventricular TachycardiaAuke T Bergeman, Peter Lauffer, Johanna C Herkert, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|July 24, 2023
MYH7 p.(Arg1712Gln) is pathogenic founder variant causing hypertrophic cardiomyopathy with overall relatively delayed onsetLuisa Marsili, Freyja H M van Lint, Francesco Russo, et al.
The Journal of Investigative Dermatology|September 16, 2023
Disruption of TUFT1, a Desmosome-Associated Protein, Causes Skin Fragility, Woolly Hair, and Palmoplantar KeratodermaAnnemieke J M H Verkerk, Daniela Andrei, Mathilde C S C Vermeer, et al.
Nature Genetics|February 18, 2025
Large-scale genome-wide association analyses identify novel genetic loci and mechanisms in hypertrophic cardiomyopathyRafik Tadros, Sean L Zheng, Christopher Grace, et al.
Medrxiv : the Preprint Server for Health Sciences|July 15, 2024
Biallelic variants in <i>POPDC2</i> cause a novel autosomal recessive syndrome presenting with cardiac conduction defects and variable hypertrophic cardiomyopathyMichele Nicastro, Alexa M C Vermeer, Pieter G Postema, et al.
Nature Genetics|January 26, 2021
Shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effectRafik Tadros, Catherine Francis, Xiao Xu, et al.
Pageof 21

Showing results (191-200 of 201) with videos related to

Sort By:
Pageof 21
Science Translational Medicine|July 22, 2021
Dynamic loading of human engineered heart tissue enhances contractile function and drives a desmosome-linked disease phenotypeJacqueline M Bliley, Mathilde C S C Vermeer, Rebecca M Duffy, et al.
JACC. Cardiooncology|July 3, 2023
Evaluation of Senescence and Its Prevention in Doxorubicin-Induced Cardiotoxicity Using Dynamic Engineered Heart TissuesAnnet N Linders, Itamar B Dias, Ekaterina S Ovchinnikova, et al.
Clinical Lung Cancer|April 22, 2025
The Toxicity Profile of Pemetrexed in Non-Small Cell Lung Cancer Patients With Moderate Renal Impairment: A Retrospective Cohort StudyMart P Kicken, Rob Ter Heine, Intissar Azarfane, et al.
Circulation. Genomic and Precision Medicine|May 18, 2023
Genetic Burden of <i>TNNI3K</i> in Diagnostic Testing of Patients With Dilated Cardiomyopathy and Supraventricular ArrhythmiasCaroline Pham, Karolina Andrzejczyk, Sean J Jurgens, et al.
Circulation. Genomic and Precision Medicine|April 10, 2026
Novel RYR2-A4510T Variant Presenting Both as Autosomal Dominant and Autosomal Recessive Catecholaminergic Polymorphic Ventricular TachycardiaAuke T Bergeman, Peter Lauffer, Johanna C Herkert, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|July 24, 2023
MYH7 p.(Arg1712Gln) is pathogenic founder variant causing hypertrophic cardiomyopathy with overall relatively delayed onsetLuisa Marsili, Freyja H M van Lint, Francesco Russo, et al.
The Journal of Investigative Dermatology|September 16, 2023
Disruption of TUFT1, a Desmosome-Associated Protein, Causes Skin Fragility, Woolly Hair, and Palmoplantar KeratodermaAnnemieke J M H Verkerk, Daniela Andrei, Mathilde C S C Vermeer, et al.
Nature Genetics|February 18, 2025
Large-scale genome-wide association analyses identify novel genetic loci and mechanisms in hypertrophic cardiomyopathyRafik Tadros, Sean L Zheng, Christopher Grace, et al.
Medrxiv : the Preprint Server for Health Sciences|July 15, 2024
Biallelic variants in <i>POPDC2</i> cause a novel autosomal recessive syndrome presenting with cardiac conduction defects and variable hypertrophic cardiomyopathyMichele Nicastro, Alexa M C Vermeer, Pieter G Postema, et al.
Nature Genetics|January 26, 2021
Shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effectRafik Tadros, Catherine Francis, Xiao Xu, et al.
Pageof 21